Pacific Biosciences (PACB) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
The meeting was called to order by the CEO, who outlined the agenda and introduced the board and executive team in attendance.
The agenda included formal proposals, voting, and a Q&A session for stockholders.
Board and executive committee updates
Directors and key executives, including the CFO, Chief People Officer, and General Counsel, were introduced as present.
The Inspector of Election, legal counsel, and the independent auditor from Ernst & Young were also in attendance.
Shareholder proposals
Six proposals were presented: election of Class II directors, ratification of the auditor, advisory vote on executive compensation, amendment to the 2020 Equity Incentive Plan, declassification of the board, and limitation of officer liability.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Pacific Biosciences
- Record consumable growth, Basecamp AI deal, and SPRQ-Nx launch drive strong outlook.PACB
Jefferies Global Healthcare Conference 20264 Jun 2026 - All proposals, including director elections and equity plan amendment, were approved.PACB
AGM 20263 Jun 2026 - Director elections, auditor ratification, and equity plan expansion headline this year's proxy.PACB
Proxy filing22 May 2026 - Record consumable revenue and improved margins offset weaker instrument sales in Q1 2026.PACB
Q1 20268 May 2026 - Clinical growth, global expansion, and SPARQ-Nx innovation set the stage for transformative years ahead.PACB
TD Cowen 46th Annual Health Care Conference27 Apr 2026 - Virtual annual meeting to vote on directors, auditor, compensation, and equity plan amendment.PACB
Proxy filing23 Apr 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.PACB
Proxy filing23 Apr 2026 - Record consumables growth, margin gains, and $48M asset sale set up for up to 12% growth in 2026.PACB
Q4 202513 Apr 2026 - Clinical expansion, innovation, and margin gains drive growth amid global market shifts.PACB
TD Cowen 45th Annual Healthcare Conference3 Feb 2026